The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme—A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks-Reference-Cited by-同舟云学术

The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme—A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks

Published:1980-04 Issue:4 Volume:35 Page:439-449
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Fears R.,Richards D.H.,Ferres H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. A reappraisal of the mechanisms of hypocholesterolaemic action of therapeutic agents;Sodhi;Adv. Exp. Med. Biol.,1978

2. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites have hypocholesterolaemic activity;Endo;FEBS Lett.,1976

3. ML-236A, ML-236B and ML-236C, new inhibitors produced by Penicillium citrinum;Endo;J. Antibiot.,1976

4. Crystal and molecular structure of Compactin, a new antifungal metabolite from Penicillium brevicompactum;Brown;J. Chem. Soc. Perkin I,1976

5. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with Compactin (ML-236B), a competitive inhibitor of the reductase;Brown;J. Biol. Chem.,1978

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women;Pharmaceuticals;2020-11-25

2. Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia;Hypertension;2020-01

3. Fungal Bioactive Compounds in Pharmaceutical Research and Development;Current Bioactive Compounds;2019-03-12

4. Lipid lowering agents of natural origin: An account of some promising chemotypes;European Journal of Medicinal Chemistry;2017-11

5. Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials;British Journal of Clinical Pharmacology;2016-02-02